What does the Cancer Breakthrough Fund invest in?
the Cancer Breakthrough Fund invests most often at Series A (100% of the rounds on record).
Last cheque observed Sep 2026; 1 cheques on record.
Deploying nowVC firm
1 cheques in the last 12 months
Mostly Series A: 100% of its rounds
Every round we can evidence, newest first1 appearances
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The latest companies the Cancer Breakthrough Fund put money into.
the Cancer Breakthrough Fund invests most often at Series A (100% of the rounds on record).
1 investments on record, 1 of them in the last 12 months. The most recent was in Sept 2026.
Its most recent investments on record: Altis Labs (Series A, Sept 2026).
The median round it joins is $25M.
Yes: it is actively investing, with 1 investments in the last 12 months.
the Cancer Breakthrough Fund is a VC firm.
From 3 articles and filings naming it in a round, public registers and its own website, checked and rebuilt every night.
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it